Tirzepatide is a GLP-1 and GIP receptor–based therapy that may be prescribed as part of a medically supervised program to support blood sugar regulation and metabolic function in adults. It is typically used alongside lifestyle modifications such as nutrition and physical activity.
Contraindications
Tirzepatide may not be appropriate for individuals with:
A personal or family history of medullary thyroid carcinoma (MTC)
Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Severe gastrointestinal conditions, including gastroparesis
A full medical evaluation is required to determine eligibility.
Warnings and Precautions
Thyroid Tumor Risk
Medications in this class have been associated with thyroid C-cell tumors in certain cases. Patients should be evaluated for risk factors prior to starting therapy and monitored for symptoms such as neck swelling, difficulty swallowing, or persistent hoarseness.
Pancreatitis
Inflammation of the pancreas has been reported with GLP-1–based therapies. Patients should be aware of symptoms such as severe abdominal pain that may radiate to the back and seek immediate medical attention if they occur.
Hypoglycemia Risk
The risk of low blood sugar may increase when tirzepatide is used alongside insulin or medications that increase insulin production. Dose adjustments may be necessary.
Kidney Function
Changes in kidney function, including worsening of pre-existing conditions, have been reported. Monitoring may be recommended, particularly in individuals with known kidney concerns.
Allergic Reactions
Serious allergic reactions, including swelling, rash, or difficulty breathing, may occur. Immediate medical attention should be sought if symptoms develop.
Gastrointestinal Effects
Some individuals may experience nausea, vomiting, diarrhea, constipation, or abdominal discomfort. These symptoms are often temporary and may improve over time or with dose adjustments.
Common Side Effects
The most frequently reported side effects include:
Nausea
Vomiting
Diarrhea
Abdominal discomfort
Constipation
Pregnancy and Breastfeeding
Tirzepatide is not recommended during pregnancy due to potential risk to the fetus. It is not known whether tirzepatide is present in breast milk, so caution is advised for individuals who are breastfeeding.
Drug Interactions
Caution should be used when taking tirzepatide alongside:
Medications that affect gastric emptying or absorption
Medications that increase the risk of hypoglycemia
Patients should inform their provider of all medications, supplements, and herbal products they are using.
Patient Guidance
Patients should be counseled on:
The importance of adhering to their prescribed treatment plan
Maintaining appropriate nutrition and physical activity
Recognizing symptoms of potential adverse effects
When to seek medical attention
Vybrant Health and Wellness Approach
At Vybrant Health and Wellness, tirzepatide is prescribed as part of a comprehensive, medically supervised program. Treatment plans are individualized based on your health history, goals, and clinical needs, with ongoing monitoring to support safety and effectiveness.
Compounded tirzepatide offered through our clinic is prepared by a licensed compounding pharmacy. These formulations are not FDA-approved and are prescribed based on individualized medical evaluation.
Disclaimer
This information is provided for educational purposes only and does not replace professional medical advice. Tirzepatide has not been evaluated by the Food and Drug Administration in its compounded form and is not intended to diagnose, treat, cure, or prevent any disease.